USPC Patent Classifications

Links will help build a uspc search at the uspto for you.

Class 514 drug, bio-affecting and body treating compositions
uspcdescription
514/1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai)
514/1.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai
514/1.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.2) transporter affecting or utilizing
514/1.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.3) prodrug utilizing
514/1.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.4) sepsis affecting
514/1.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.5) respiratory distress syndrome (e.g., ards, irds, etc.) affecting
514/1.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.6) pneumonia affecting
514/1.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.7) asthma affecting
514/1.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.8) cystic fibrosis affecting
514/1.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (1.9) arteriosclerosis (e.g., atherosclerosis, etc.) affecting
514/2.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.1) endotoxin (e.g., lps, etc.) affecting
514/2.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.2) bactericidal/permeability-increasing (bpi) protein affecting or utilizing
514/2.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting
514/2.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting
514/2.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (2.5) lactoferrin
514/2.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (2.6) streptococcus
514/2.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (2.7) staphylococcus (e.g., staphylococcus aureus, etc.)
514/2.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (2.8) gram negative bacterium (e.g., escherichia coli, salmonella, helicobacter, etc.)
514/2.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (2.9) cyclopeptide utilizing
514/3.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (3.1) glycopeptide utilizing
514/3.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (2.4) bacterium (e.g., bacillus, etc.) destroying or inhibiting (3.2) amphiphilic or oligomer modified peptide (e.g., magainin, peptide nucleic acid, or pegylated peptide, etc.) utilizing
514/3.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.3) fungus (e.g., athlete's foot, ringworm, etc.) destroying or inhibiting
514/3.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.3) fungus (e.g., athlete's foot, ringworm, etc.) destroying or inhibiting (3.4) candida (e.g., candida albicans, etc.)
514/3.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.3) fungus (e.g., athlete's foot, ringworm, etc.) destroying or inhibiting (3.5) yeast
514/3.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.3) fungus (e.g., athlete's foot, ringworm, etc.) destroying or inhibiting (3.6) cyclopeptide utilizing
514/3.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting
514/3.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting (3.8) human immunodeficiency virus (hiv)
514/3.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting (3.8) human immunodeficiency virus (hiv) (3.9) cluster of differentiation protein (e.g., cd4, etc.) affecting
514/4.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting (3.8) human immunodeficiency virus (hiv) (4.1) hiv protease inhibitor affecting or utilizing
514/4.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting (4.2) herpesviridae
514/4.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (3.7) virus destroying or inhibiting (4.3) hepatitis
514/4.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (2.3) micro-organism destroying or inhibiting (4.4) protozoa destroying or inhibiting
514/4.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.5) insect destroying or inhibiting
514/4.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.6) parasite (e.g., tapeworm, roundworm, nematode, etc.) destroying or inhibiting
514/4.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.7) lactation affecting
514/4.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.8) weight regulation affecting
514/4.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.8) weight regulation affecting (4.9) appetite or satiation affecting
514/5.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.8) weight regulation affecting (5.1) growth hormone (gh) or derivative utilizing
514/5.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.8) weight regulation affecting (5.2) neuropeptide (e.g., npy, pyy, dynorphin, etc.) or derivative utilizing
514/5.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (4.8) weight regulation affecting (5.3) peptide hormone or derivative utilizing
514/5.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.4) iron affecting
514/5.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.5) nutrition enhancement or support
514/5.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.5) nutrition enhancement or support (5.6) containing whey
514/5.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.5) nutrition enhancement or support (5.7) containing casein
514/5.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.8) leptin or derivative affecting or utilizing
514/5.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing
514/6.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.1) truncated insulin
514/6.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.2) a-chain modified insulin
514/6.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.3) b-chain modified insulin
514/6.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.4) zinc containing
514/6.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.5) with an additional active ingredient
514/6.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (5.9) insulin or derivative utilizing (6.5) with an additional active ingredient (6.6) with protamine
514/6.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.7) insulin affecting
514/6.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.8) blood sugar affecting
514/6.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.8) blood sugar affecting (6.9) diabetes
514/7.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.8) blood sugar affecting (6.9) diabetes (7.1) somatostatin or derivative affecting or utilizing
514/7.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.8) blood sugar affecting (6.9) diabetes (7.2) glucagon, glucagon-like peptide (e.g., glp-1, etc.) or derivative affecting or utilizing
514/7.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (6.8) blood sugar affecting (6.9) diabetes (7.3) type i diabetes
514/7.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.4) lipid or cholesterol affecting (e.g., dyslipidemia, etc.)
514/7.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.5) protein tyrosine kinase (ptk) affecting
514/7.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing
514/7.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (7.7) erythropoietin (epo) or derivative
514/7.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (7.8) thrombopoietin (tpo) or derivative
514/7.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (7.9) hematopoiesis affecting
514/8.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.1) vascular endothelial growth factor (e.g., vegf-a, vegf-b, etc.) or derivative
514/8.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.2) platelet-derived growth factor (pdgf) or derivative
514/8.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.3) nerve tissue or nerve cell growth affecting
514/8.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.3) nerve tissue or nerve cell growth affecting (8.4) nerve growth factor (ngf) or derivative
514/8.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.5) insulin-like growth factor (igf) or derivative
514/8.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.5) insulin-like growth factor (igf) or derivative (8.6) insulin-like growth factor 1 (igf-1) or derivative
514/8.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.5) insulin-like growth factor (igf) or derivative (8.7) insulin-like growth factor binding protein (igfbp) or derivative
514/8.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.8) bone morphogenic protein (bmp) or derivative
514/8.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (8.9) transforming growth factor (tgf) or derivative
514/9.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.1) fibroblast growth factor (fgf) or derivative
514/9.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.1) fibroblast growth factor (fgf) or derivative (9.2) keratinocyte growth factor (kgf) or derivative
514/9.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.3) fibronectin or derivative
514/9.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.4) wound healing or wound repair affecting
514/9.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.5) hepatocyte growth factor (hgf) or derivative
514/9.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (7.6) growth factor or derivative affecting or utilizing (9.6) epidermal growth factor (egf) or epidermal growth factor-like or derivative
514/9.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing
514/9.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility
514/9.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (9.9) follicle-stimulating hormone (fsh) or derivative
514/10.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.1) luteinizing hormone (lh) or derivative
514/10.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.2) androgen (e.g., testosterone, etc.) or estrogen affecting
514/10.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.3) gonadotropin-releasing hormone (gnrh) or derivative
514/10.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.3) gonadotropin-releasing hormone (gnrh) or derivative (10.4) cetrorelix, leuprolide, or deslorelin utilizing
514/10.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.3) gonadotropin-releasing hormone (gnrh) or derivative (10.5) ovulation affecting
514/10.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (9.8) fertility (10.3) gonadotropin-releasing hormone (gnrh) or derivative (10.6) synthetic gonadotropin-releasing hormone antagonist
514/10.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (10.7) melanocortin (e.g., melanocyte-stimulating hormone (msh), etc.) or derivative
514/10.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (10.7) melanocortin (e.g., melanocyte-stimulating hormone (msh), etc.) or derivative (10.8) corticotropin or derivative
514/10.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (10.9) vasopressin or derivative
514/11.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.1) somatostatin or derivative
514/11.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.2) growth-hormone-releasing hormone (ghrh) or derivative
514/11.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.3) growth hormone (gh) or derivative
514/11.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.3) growth hormone (gh) or derivative (11.4) human growth hormone (hgh) or derivative
514/11.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.5) prolactin or derivative
514/11.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.6) oxytocin or derivative
514/11.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.7) glucagon, glucagon-like peptide (e.g., glp-1, glp-2, etc.) or derivative
514/11.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.8) parathyroid hormone (pth) or derivative
514/11.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (11.9) calcitonin or derivative
514/12.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.1) muscle contraction affecting (e.g., muscle twitch, muscle relaxation, etc.)
514/12.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.2) anti-inflammatory
514/12.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.3) gastrin hormone or derivative
514/12.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.4) natriuretic peptide or derivative (e.g., atrial natriuretic peptide, brain natriuretic peptide, etc.)
514/12.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.5) bradykinin or derivative
514/12.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.6) cholecystokinin (cck) or derivative
514/12.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.7) relaxin or derivative
514/12.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.8) secretin or derivative
514/12.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (12.9) thymosin (e.g., thymosin (alpha 1, thymosin beta 4, etc.) or derivative
514/13.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (9.7) hormone or derivative affecting or utilizing (13.1) vasoactive intestinal peptide (vip) or derivative
514/13.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.2) digestive tract ulcer affecting
514/13.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.3) angiogenesis affecting
514/13.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.4) blood substitute
514/13.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing
514/13.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.6) fibrin or derivative affecting or utilizing
514/13.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting
514/13.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (13.8) platelet aggregation or adhesion affecting
514/13.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (13.8) platelet aggregation or adhesion affecting (13.9) glycoprotein iib/iiia affecting
514/14.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.1) factor viii or derivative affecting or utilizing
514/14.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting
514/14.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.3) factor viia affecting
514/14.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.4) factor xa affecting
514/14.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.4) factor xa affecting (14.5) tissue factor pathway inhibitor (tfpi) utilizing
514/14.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.6) urokinase affecting
514/14.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.7) thrombin affecting
514/14.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.2) plasma protease affecting (14.7) thrombin affecting (14.8) hirudin or derivative utilizing
514/14.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (13.7) coagulation affecting (14.9) thrombosis affecting
514/15.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (15.1) oxidative stress affecting
514/15.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (15.2) albumin or derivative affecting or utilizing
514/15.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (13.5) blood affecting or blood protein utilizing (15.3) plasma protein affecting or utilizing
514/15.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.4) kidney affecting
514/15.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.5) surfactant protein (e.g., sp-a, sp-b, etc.) or derivative affecting or utilizing
514/15.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting
514/15.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting (15.7) hypertension
514/15.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting (15.7) hypertension (15.8) renin inhibitor affecting or utilizing
514/15.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting (15.7) hypertension (15.8) renin inhibitor affecting or utilizing (15.9) dipeptide renin inhibitor
514/16.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting (15.7) hypertension (16.1) endothelin (e.g., et-2, et-3, etc.) or derivative affecting or utilizing
514/16.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (15.6) blood pressure affecting (15.7) hypertension (16.2) angiotensin converting enzyme (ace) affecting
514/16.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.3) angiotensin converting enzyme (ace) affecting
514/16.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.4) cardiac disease (i.e., heart disease) affecting
514/16.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.5) tissue development affecting
514/16.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.6) rheumatoid arthritis affecting
514/16.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.7) bone affecting
514/16.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.7) bone affecting (16.8) osteoarthritis
514/16.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (16.7) bone affecting (16.9) osteoporosis
514/17.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.1) cartilage affecting
514/17.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.2) collagen or derivative affecting or utilizing
514/17.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.3) n-methyl-d-aspartate (nmda) receptor affecting
514/17.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.4) ion channel protein affecting
514/17.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.5) mental disorder or mental illness (e.g., psychoses, etc.) affecting
514/17.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.5) mental disorder or mental illness (e.g., psychoses, etc.) affecting (17.6) anti-depressant or derivative affecting or utilizing
514/17.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting
514/17.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (17.8) alzheimer's disease
514/17.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (17.9) multiple sclerosis
514/18.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (18.1) neurotransmitter or derivative affecting or utilizing
514/18.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (18.2) neuropathy affecting
514/18.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (18.3) pain affecting
514/18.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (18.3) pain affecting (18.4) opioid receptor affecting
514/18.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (17.7) nervous system (e.g., central nervous system (cns), etc.) affecting (18.3) pain affecting (18.5) enkephalin or derivative affecting or utilizing
514/18.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (18.6) skin affecting
514/18.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (18.6) skin affecting (18.7) anti-inflammatory
514/18.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (18.6) skin affecting (18.8) cosmetic enhancement or care
514/18.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (18.9) apoptosis affecting
514/19.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.1) cellular adhesion affecting or cell adhesion molecule (cam) affecting or utilizing
514/19.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting
514/19.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer
514/19.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.4) breast
514/19.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.5) prostate
514/19.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.6) leukemia
514/19.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.7) bombesin or derivative affecting or utilizing
514/19.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.8) metastasis affecting
514/19.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (19.2) neoplastic condition affecting (19.3) cancer (19.9) cyclopeptide utilizing
514/20.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.1) protease inhibitor affecting or utilizing
514/20.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.1) protease inhibitor affecting or utilizing (20.2) cysteine protease inhibitor affecting or utilizing
514/20.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.1) protease inhibitor affecting or utilizing (20.3) serine protease inhibitor affecting or utilizing
514/20.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.1) protease inhibitor affecting or utilizing (20.3) serine protease inhibitor affecting or utilizing (20.4) elastase inhibitor affecting or utilizing
514/20.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.5) cyclosporine or derivative utilizing
514/20.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.6) g-protein coupled receptor (gpcr) affecting
514/20.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.7) hair affecting
514/20.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.8) eye affecting
514/20.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (20.9) glycopeptide utilizing
514/21.1514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.1) cyclopeptide utilizing
514/21.2514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.2) 100 or more amino acid residues in the peptide chain
514/21.3514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.3) 25 to 99 amino acid residues in the peptide chain
514/21.4514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.4) 16 to 24 amino acid residues in the peptide chain
514/21.5514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.5) 12 to 15 amino acid residues in the peptide chain
514/21.6514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.6) 9 to 11 amino acid residues in the peptide chain
514/21.7514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.7) 7 or 8 amino acid residues in the peptide chain
514/21.8514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.8) 5 or 6 amino acid residues in the peptide chain
514/21.9514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.9) 3 or 4 amino acid residues in the peptide chain
514/21.91514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.91) 2 amino acid residues in the peptide chain
514/21.92514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (1.1) peptide (e.g., protein, etc.) containing doai (21.92) produced by or extracted from animal tissue
514/22514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (22) lignin or derivative doai
514/23514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai
514/24514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (24) s-glycoside
514/25514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside
514/26514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (26) cyclopentanohydrophenanthrene ring system
514/27514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (27) oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring
514/28514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (27) oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring (28) the hetero ring has 8 or more ring carbons
514/29514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (27) oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring (28) the hetero ring has 8 or more ring carbons (29) the hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.)
514/30514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (27) oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring (28) the hetero ring has 8 or more ring carbons (30) the hetero ring has exactly 15 ring carbons
514/31514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (27) oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring (28) the hetero ring has 8 or more ring carbons (31) the hetero ring has 20 or more ring carbons (e.g., nystatin, etc.)
514/32514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (32) oxygen of the saccharide radical bonded to a nonsaccharide hetero ring by acyclic carbon bonding
514/33514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (33) oxygen of the saccharide radical bonded directly to a polycyclo ring system of three or more carbocyclic rings
514/34514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (33) oxygen of the saccharide radical bonded directly to a polycyclo ring system of three or more carbocyclic rings (34) oxygen of the saccharide radical bonded directly to a polycyclo ring system of four carbocyclic rings (e.g., daunomycin, etc.)
514/35514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring
514/36514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring
514/37514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring (37) the nitrogen atoms are in n-c(=n)-n groups (e.g., streptomycin, etc.)
514/38514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring (38) two saccharide radicals bonded through only oxygen to adjacent ring carbons of the cyclohexyl ring
514/39514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring (38) two saccharide radicals bonded through only oxygen to adjacent ring carbons of the cyclohexyl ring (39) three or more saccharide radicals (e.g., neomycin, etc.)
514/40514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring (40) two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring
514/41514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (25) o-glycoside (35) oxygen of the saccharide radical bonded directly to a cyclohexyl ring (36) two or more nitrogen atoms bonded directly to the cyclohexyl ring (40) two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring (41) kanamycin or derivative
514/42514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside
514/43514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring
514/44R514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (44r) polynucleotide (e.g., rna, dna, etc.)
514/44A514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (44r) polynucleotide (e.g., rna, dna, etc.) (44a) antisense or rna interference
514/45514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (45) purines (including hydrogenated) (e.g., adenine, guanine, etc.)
514/46514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (45) purines (including hydrogenated) (e.g., adenine, guanine, etc.) (46) adenosine or derivative
514/47514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (45) purines (including hydrogenated) (e.g., adenine, guanine, etc.) (46) adenosine or derivative (47) phosphorus containing
514/48514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (45) purines (including hydrogenated) (e.g., adenine, guanine, etc.) (48) phosphorus containing
514/49514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (49) pyrimidines (including hydrogenated) (e.g., cytosine, etc.)
514/50514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (49) pyrimidines (including hydrogenated) (e.g., cytosine, etc.) (50) 2,4-diketone pyrimidine or derivative (e.g., uracil, etc.)
514/51514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (49) pyrimidines (including hydrogenated) (e.g., cytosine, etc.) (50) 2,4-diketone pyrimidine or derivative (e.g., uracil, etc.) (51) phosphorus containing
514/52514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (42) n-glycoside (43) nitrogen containing hetero ring (52) phosphorus containing (e.g., vitamin b12, etc.)
514/53514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (53) dissacharide
514/54514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide
514/55514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (55) chitin or derivative
514/56514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (56) heparin or derivative
514/57514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (57) cellulose or derivative
514/58514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (58) dextrin or derivative
514/59514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (59) dextran or derivative
514/60514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (60) starch or derivative
514/61514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (54) polysaccharide (61) tri- or tetrasaccharide
514/62514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (23) carbohydrate (i.e., saccharide radical containing) doai (62) glucosamine or derivative
514/63514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (63) silicon containing doai
514/64514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (64) boron containing doai
514/65514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai
514/66514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (66) with heterocyclic compound
514/67514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (66) with heterocyclic compound (67) methylenedioxyphenyl group containing (e.g., piperonyl butoxide, etc.)
514/68514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (68) with carboxylic acid ester
514/69514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (69) with carboxylic acid metal salt
514/70514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (70) with organic nitrogen containing compound
514/71514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (70) with organic nitrogen containing compound (71) sulfur containing organic nitrogen compound
514/72514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (72) with organic oxygen containing compound
514/73514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (72) with organic oxygen containing compound (73) phosphorus or halogen containing organic oxygen compound
514/74514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (65) pyrethrum plant derived material or plant derived rotenone compound containing doai (74) with hydrocarbon or halohydrocarbon
514/75514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (75) phosphorus containing other than solely as part of an inorganic ion in an addition salt doai
514/76514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (75) phosphorus containing other than solely as part of an inorganic ion in an addition salt doai (76) amine addition salt of organic phosphorus containing acid
514/77514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (75) phosphorus containing other than solely as part of an inorganic ion in an addition salt doai (77) inner salt (e.g., betaine, etc.)
514/78514 drug, bio-affecting and body treating compositions/(1) designated organic active ingredient containing (doai) (75) phosphorus containing other than solely as part of an inorganic ion in an addition salt doai (77) inner salt (e.g., betaine, etc.) (78) lecithins
Next Page

Back to the Class List